Combination of bempedoic acid and ezetimibe
Pre-clinicalRecruiting 2 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Hypercholesterolaemia
Conditions
Primary Hypercholesterolaemia, Mixed Dyslipidemia
Trial Timeline
Jan 30, 2026 → Mar 1, 2029
NCT ID
NCT07206472About Combination of bempedoic acid and ezetimibe
Combination of bempedoic acid and ezetimibe is a pre-clinical stage product being developed by Daiichi Sankyo for Primary Hypercholesterolaemia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07206472. Target conditions include Primary Hypercholesterolaemia, Mixed Dyslipidemia.
What happened to similar drugs?
20 of 20 similar drugs in Primary Hypercholesterolaemia were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
3
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07206472 | Pre-clinical | Recruiting |
Competing Products
20 competing products in Primary Hypercholesterolaemia